UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring

Clinical and experimental allergy, 2002-07, Vol.32 (7), p.1020-1028

2002

Volltextzugriff (PDF)

Montelukast improves symptoms of seasonal allergic rhinitis over a 4‐week treatment period

Allergy (Copenhagen), 2003-12, Vol.58 (12), p.1268-1276

2003

Volltextzugriff (PDF)

Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial

The European respiratory journal, 1999-07, Vol.14 (1), p.12-18

1999

Volltextzugriff (PDF)

What are minimal important changes for asthma measures in a clinical trial?

The European respiratory journal, 1999-07, Vol.14 (1), p.23-27

1999

Volltextzugriff (PDF)

Increase in urinary leukotriene LTE4 levels in acute asthma: correlation with airflow limitation

Thorax, 2004-02, Vol.59 (2), p.100-104

2004

Volltextzugriff (PDF)

Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years

Pediatrics (Evanston), 2001-09, Vol.108 (3), p.E48-e48

2001

Volltextzugriff (PDF)

Correlation of airway obstruction and patient-reported endpoints in clinical studies

The European respiratory journal, 2001-02, Vol.17 (2), p.220-224

2001

Volltextzugriff (PDF)

Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: A randomized, placebo-controlled clinical trial

Journal of allergy and clinical immunology, 2000-05, Vol.105 (5), p.917-922

2000

Volltextzugriff (PDF)

Variability and lack of predictive ability of asthma end-points in clinical trials

The European respiratory journal, 2002-11, Vol.20 (5), p.1102-1109

2002

Volltextzugriff (PDF)

Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist

Thorax, 1997-12, Vol.52 (12), p.1030-1035

1997

Volltextzugriff (PDF)

Montelukast and bronchial inflammation in asthma: A randomised, double-blind placebo-controlled trial

Respiratory medicine, 2009-07, Vol.103 (7), p.995-1003

2009

Volltextzugriff (PDF)

Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged ≥ 6 years

Clinical and experimental allergy, 2001-01, Vol.31 (1), p.77-87

2001

Volltextzugriff (PDF)

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures

The Lancet (British edition), 1996-12, Vol.348 (9041), p.1535-1541

1996

Volltextzugriff (PDF)

Long-term asthma control with oral montelukast and inhaled beclomethasone for adults and children 6 years and older

Clinical and experimental allergy, 2001-06, Vol.31 (6), p.845-854

2001

Volltextzugriff (PDF)

Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma

The Journal of pediatrics, 1998-09, Vol.133 (3), p.424-428

1998

Volltextzugriff (PDF)

Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids

Thorax, 1997-01, Vol.52 (1), p.45-48

1997

Volltextzugriff (PDF)

An oral selective M3 cholinergic receptor antagonist in COPD

The European respiratory journal, 2006-10, Vol.28 (4), p.772-780

2006

Volltextzugriff (PDF)

Comparison of the effects of intravenous and oral montelukast on airway function: a double blind, placebo controlled, three period, crossover study in asthmatic patients

Thorax, 2000-04, Vol.55 (4), p.260-265

2000

Volltextzugriff (PDF)

Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma

The European respiratory journal, 1998-06, Vol.11 (6), p.1232-1239

1998

Volltextzugriff (PDF)

Measurement characteristics of two asthma symptom diary scales for use in clinical trials

The European respiratory journal, 1997-03, Vol.10 (3), p.646-651

1997

Volltextzugriff (PDF)

Effects of montelukast (MK-0476), a new potent cysteinyl leukotriene (LTD 4) receptor antagonist, in patients with chronic asthma

Journal of allergy and clinical immunology, 1996-09, Vol.98 (3), p.528-534

1996

Volltextzugriff (PDF)

Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone

The European respiratory journal, 2003-01, Vol.21 (1), p.123-128

2003

Volltextzugriff (PDF)

Dose-related protection of exercise bronchoconstriction by montelukast, a cysteinyl leukotriene-receptor antagonist, at the end of a once-daily dosing interval

Clinical pharmacology and therapeutics, 1997-11, Vol.62 (5), p.556-561

1997

Volltextzugriff (PDF)

Analysis of montelukast in mild persistent asthmatic patients with near-normal lung function

Respiratory medicine, 2001-05, Vol.95 (5), p.379-386

2001

Volltextzugriff (PDF)

Oral Montelukast, Inhaled Beclomethasone, and Placebo for Chronic Asthma: A Randomized, Controlled Trial

Annals of internal medicine, 1999-03, Vol.130 (6), p.487

Malmstrom, Kerstin

1999

Volltextzugriff (PDF)

1 – 25 von 1.972

Suche als RSS-Feed

Aktive Filter

SpracheEnglisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.683)
Mit Volltextzugriff
(1.609)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Aids
(76)
The Journal Of Infectious Diseases
(37)
Physical Review Letters
(36)
Clinical Infectious Diseases
(29)
Hiv Medicine
(25)
Journal Of Allergy And Clinical Immunology
(24)
Plos One
(22)
Journal Of Investigative Dermatology
(20)
The Lancet
(20)
The journal Of Infectious Diseases
(20)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring

Montelukast improves symptoms of seasonal allergic rhinitis over a 4‐week treatment period

Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial

What are minimal important changes for asthma measures in a clinical trial?

Increase in urinary leukotriene LTE4 levels in acute asthma: correlation with airflow limitation

Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years

Correlation of airway obstruction and patient-reported endpoints in clinical studies

Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: A randomized, placebo-controlled clinical trial

Variability and lack of predictive ability of asthma end-points in clinical trials

Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist

Montelukast and bronchial inflammation in asthma: A randomised, double-blind placebo-controlled trial

Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged ≥ 6 years

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures

Long-term asthma control with oral montelukast and inhaled beclomethasone for adults and children 6 years and older

Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma

Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids

An oral selective M3 cholinergic receptor antagonist in COPD

Comparison of the effects of intravenous and oral montelukast on airway function: a double blind, placebo controlled, three period, crossover study in asthmatic patients

Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma

Measurement characteristics of two asthma symptom diary scales for use in clinical trials

Effects of montelukast (MK-0476), a new potent cysteinyl leukotriene (LTD 4) receptor antagonist, in patients with chronic asthma

Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone

Dose-related protection of exercise bronchoconstriction by montelukast, a cysteinyl leukotriene-receptor antagonist, at the end of a once-daily dosing interval

Analysis of montelukast in mild persistent asthmatic patients with near-normal lung function

Oral Montelukast, Inhaled Beclomethasone, and Placebo for Chronic Asthma: A Randomized, Controlled Trial

Aktive Filter

Suchergebnisse filtern